Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.zyduscadila.com | |
Market Cap | 92,794.90 Cr. | |
Enterprise Value(EV) | 92,037.80 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 29.55 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 31.20 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 40.73 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 187.28 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.92 | Calculated using Price: 922.20 |
Dividend Yield | 0.65 | Period Ending 2023-03 |
No. of Shares Subscribed | 100.62 Cr. | 1,006,233,990 Shares |
FaceValue | 1 | |
About Zydus Lifesciences Ltd. | ||
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products. Innovation is the backbone of the company as it ensures business sustainability through continuous availability of new products for various businesses. |
1 Day |
|
-1.11% |
1 Week |
|
-6.85% |
1 Month |
|
-6.52% |
3 Month |
|
+30.63% |
6 Month |
|
+58.72% |
1 Year |
|
+79.53% |
2 Year |
|
+153.93% |
5 Year |
|
+174.88% |
10 Year |
|
+375.99% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 30.85 | 38.62 | 23.47 | 22.5 | 19.36 | 11.32 | 18.88 | 15.51 | 11.6 | |
Return on Capital Employed (%) | 23.21 | 28.6 | 16.52 | 18.55 | 15.89 | 10.02 | 14.38 | 15.3 | 13.64 | |
Return on Assets (%) | 13.93 | 20.14 | 12.2 | 11.23 | 9.34 | 5.18 | 9.66 | 9.4 | 7.82 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 4,252 | 5,699 | 6,960 | 8,745 | 10,386 | 10,376 | 12,992 | 17,000 | 17,516 | 18,733 | |
Non Curr. Liab. | 1,342 | 736 | 1,903 | 2,122 | 3,491 | 2,854 | 19 | -194 | -725 | -1,116 | |
Curr. Liab. | 3,285 | 3,461 | 5,306 | 6,072 | 7,343 | 8,269 | 7,861 | 7,827 | 5,527 | 4,363 | |
Minority Int. | 169 | 136 | 156 | 191 | 1,293 | 1,335 | 1,937 | 2,054 | 2,173 | 2,208 | |
Equity & Liab. | 9,047 | 10,032 | 14,325 | 17,141 | 22,513 | 22,834 | 22,810 | 26,700 | 24,494 | 24,188 | |
Non Curr. Assets | 4,820 | 5,752 | 8,303 | 8,911 | 14,015 | 14,118 | 14,094 | 14,438 | 14,478 | 14,253 | |
Curr. Assets | 4,227 | 4,280 | 6,022 | 8,201 | 8,498 | 8,715 | 8,716 | 12,095 | 10,008 | 9,935 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 9,047 | 10,032 | 14,325 | 17,141 | 22,513 | 22,834 | 22,810 | 26,700 | 24,494 | 24,188 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 8,651 | 9,427 | 9,377 | 11,905 | 13,166 | 14,253 | 14,404 | 15,110 | 17,237 | 19,024 | |
Other Income | 57 | 117 | 147 | 133 | 209 | 117 | 75 | 391 | 475 | 268 | |
Total Income | 8,709 | 9,543 | 9,524 | 12,038 | 13,374 | 14,370 | 14,479 | 15,501 | 17,712 | 19,293 | |
Total Expenditure | -6,897 | -7,097 | -7,472 | -9,058 | -10,187 | -11,473 | -11,018 | -11,935 | -13,666 | -14,118 | |
PBIDT | 1,811 | 2,446 | 2,051 | 2,980 | 3,187 | 2,897 | 3,460 | 3,565 | 4,047 | 5,175 | |
Interest | -68 | -53 | -63 | -111 | -196 | -342 | -186 | -127 | -130 | -74 | |
Depreciation | -287 | -292 | -373 | -539 | -599 | -697 | -670 | -713 | -723 | -737 | |
Taxation | -259 | -177 | -129 | -564 | -530 | -320 | -194 | -512 | -588 | -794 | |
Exceptional Items | -10 | -3 | 0 | -10 | -364 | -205 | 113 | -604 | -616 | ||
PAT | 1,186 | 1,921 | 1,486 | 1,766 | 1,852 | 1,176 | 2,206 | 2,326 | 2,002 | 2,954 | |
Minority Interest | -38 | -30 | -29 | -35 | -50 | -28 | -51 | -131 | -132 | -111 | |
Share Associate | 43 | 34 | 63 | 47 | 29 | 47 | 46 | 95 | 113 | ||
Other Related Items | 2 | ||||||||||
Consolidated Net Profit | 1,151 | 1,934 | 1,488 | 1,776 | 1,849 | 1,177 | 2,134 | 4,487 | 1,960 | 2,974 | |
Adjusted EPS | 11 | 19 | 15 | 17 | 18 | 11 | 21 | 44 | 19 | 29 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 903 | 994 | 1,894 | 1,312 | 919 | 1,282 | 2,932 | 3,294 | 2,105 | 2,689 | |
Cash Fr. Inv. | -438 | -465 | -864 | -2,872 | -974 | -4,239 | -1,012 | -725 | -1,000 | 1,171 | |
Cash Fr. Finan. | -529 | -351 | -935 | 2,316 | 52 | 1,885 | -1,528 | -2,548 | -868 | -4,400 | |
Net Change | -64 | 178 | 95 | 756 | -3 | -1,072 | 391 | 22 | 236 | -540 | |
Cash & Cash Eqvt | 613 | 790 | 837 | 1,593 | 1,590 | 779 | 1,178 | 1,087 | 1,107 | 573 |
Fri, 12 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate under Reg 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Tue, 09 Apr 2024
Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Certificate under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 |
Fri, 19 Apr 2024 |
Closing Below Previous Low |
Close Within 52 Week High Zone |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |